Yuzong Chen
Molecular Biology · 2009–2021
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 103 citations into it
Whom Yuzong Chen trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- David S. Wishart (in Molecular Biology)
Papers from Yuzong Chen's perspective
Ordered by how strongly the researchers Yuzong Chen trusts endorse each paper. Same corpus, a different order for every researcher.
- Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst (Nature Protocols)
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- Interactive XCMS Online: Simplifying Advanced Metabolomic Data Processing and Subsequent Statistical Analyses (Analytical Chemistry)
- Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry (Nature Protocols)
- Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. (Analytical Chemistry)
- Normalization of RNA-seq data using factor analysis of control genes or samples (Nature Biotechnology)
- MetaboAnalyst 3.0—making metabolomics more meaningful (Nucleic Acids Res.)
- BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities
- STATISTICAL METHODS FOR IDENTIFYING DIFFERENTIALLY EXPRESSED GENES IN REPLICATED cDNA MICROARRAY EXPERIMENTS
- DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs
Their papers
- Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics (2019) — 769 citations
- Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery (2011) — 480 citations
- Mechanisms of drug combinations: interaction and network perspectives (2009) — 563 citations
- NOREVA: normalization and evaluation of MS-based metabolomics data (2017) — 332 citations
- Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools. (2015) — 95 citations
- Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents (2021) — 531 citations